Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism

Objective: Changes in bile acids (BAs) are increasingly recognized as potential targets for non-alcoholic steatohepatitis (NASH). Kaempferol has been proved to be anti-inflammatory and reduce the disorder of lipid metabolism. In order to analyze the BA profile in NASH mice and determine the predicti...

Full description

Bibliographic Details
Main Authors: Yifei Lu, Mingmei Shao, Caiyun Zhang, Hongjiao Xiang, Junmin Wang, Tao Wu, Guang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
kaempferol
NASH
bile acid
metabolomics
metabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.946360/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.946360/full

Similar Items